by The longer term effects of Covid-19 can take many forms and there are numerous definitions of the disease. A study undertaken by HUG and UNIGE in Geneva, published on 6 July 2021, found that 39% of a group of Covid-19 patients still had symptoms after 7 months. © Wavebreakmedia Ltd | Dreamstime.com Of the 629 participants in the study who completed the interviews, 410 completed the follow-up at 7 to 9 months after a COVID-19 diagnosis in early 2020. Of this group, 39.0% reported residual symptoms at 7 to 9 months. Fatigue (20.7%) was the most common symptom, followed by loss of taste or smell (16.8%), shortness of breath (11.7%), and headache (10.0%). Some had symptoms that persisted, some had symptoms that arrived after a delay, while others had symptoms that
Topics:
Investec considers the following as important: 3) Swiss Markets and News, 3a) Health, Coronavirus Switzerland, Covid-19 Switzerland, Editor's Choice, Featured, health, newsletter
This could be interesting, too:
Investec writes The global brands artificially inflating their prices on Swiss versions of their websites
Investec writes Swiss car insurance premiums going up in 2025
Investec writes The Swiss houses that must be demolished
Investec writes Swiss rent cuts possible following fall in reference rate
The longer term effects of Covid-19 can take many forms and there are numerous definitions of the disease. A study undertaken by HUG and UNIGE in Geneva, published on 6 July 2021, found that 39% of a group of Covid-19 patients still had symptoms after 7 months.
© Wavebreakmedia Ltd | Dreamstime.com
Of the 629 participants in the study who completed the interviews, 410 completed the follow-up at 7 to 9 months after a COVID-19 diagnosis in early 2020. Of this group, 39.0% reported residual symptoms at 7 to 9 months. Fatigue (20.7%) was the most common symptom, followed by loss of taste or smell (16.8%), shortness of breath (11.7%), and headache (10.0%).
Some had symptoms that persisted, some had symptoms that arrived after a delay, while others had symptoms that came, went, and returned later.
Of the 311 participants that responded at all 3 follow-up time points, 37% reported symptom resolution by 30 to 45 days and 19% by 7 to 9 months. 27% reported symptoms at all 3 time points and 10% reported symptoms at the start and at 7 to 9 months but not at 30 to 45 days. Finally, 4% of participants reported no symptoms at all 3 time points, 2% had no symptoms at baseline but had symptoms at 30 to 45 days and 7 to 9 months, and 1 person had no symptoms at the start and 30 to 45 days but had symptoms at 7 to 9 months.
The study authors concluded that residual symptoms following SARS-CoV-2 infection are common among otherwise young and healthy persons and recommend long-term monitoring.
The mean age of those studied was 42.1 years, 60.9% were women, 25.3% were health care workers, and 70.7% had no underlying risk factors.
You Might Also Like
SNB Sight Deposits: Inflation Fear Decreasing, SNB Selling Euros
2021-07-05
Sight Deposits have fallen: The change is -0.5 bn. compared to last week, this means the SNB is selling euros and dollars.
Switzerland to open mass events and nightclubs to those with Covid certificates
2021-06-26
On 23 June 2021, Switzerland’s government announced that it was loosening a wide range of Covid-19 restrictions from Saturday. From Saturday, 26 June 2021 rules on nightclubs, large events, remote working, education and restaurants will be loosened. In addition, it will become easier for travelers to enter Switzerland.
Covid: how is Switzerland going on vaccinations?
2021-06-03
On 23 December 2021, a 90-year old resident of Luzern, was the first person in Switzerland to be vaccinated against Covid-19. In the roughly 5 months since then, more than 3 million people in Switzerland have received at least one dose of vaccine, representing around 36% of the population.
Covid: new cases down 28% in Switzerland this week
2021-05-30
This week, 5,670 new Covid-19 cases were recorded in Switzerland, down 28% from the week before (7,843), continuing the downward trend of new numbers of recorded infections. The daily number of cases on a 7-day rolling average has more than halved (-58%) in 4 weeks falling from 1,924 to 810.
Covid: 13,465 new cases in Switzerland this week
2021-05-02
This week, saw 13,465 new Covid-19 cases in Switzerland, down 5% from a week before (14,110) continuing the 5% slow down in growth of new numbers experienced last week.
© Andrii Kozlytskyi | Dreamstime.comThe 7-day average is currently 1,924, dipping below the level of 2,000 for the first time since 11 April 2021.
By 30 April 2021, 10.8% of Switzerland’s population was fully vaccinated, up from 9.6% a week earlier. This week, the number of doses administered per 100 people rose from 26.4 to 30.6, leaving Switzerland trailing behind the EU (32.1 per 100), the UK (70.9) and US (70.2).
By the end of this week, Switzerland’s reproduction rate was below 1.00 overall (0.98) with a few hotspots in central and far eastern Switzerland.
Currently, 25% of hospital beds remain
Switzerland’s low-income earners hit far harder despite lower Covid-19 infection rates
2021-02-28
The economic impact of the Covid-19 pandemic has hit low-income households far harder than those on high incomes, according to a study published by the KOF Swiss Economic Institute at ETH Zurich.
Covid: new negative test requirement for entering Switzerland
2021-02-11
From Monday 8 February 2021, many people entering Switzerland require a negative PCR test. Currently, there are restrictions on who can enter Switzerland. Generally, only those with a Swiss passport, a valid Swiss residence or cross-border permit, and those who are citizens of an EU or EFTA nation are allowed to enter Switzerland under the current Covid-19 restrictions.
Covid: Switzerland grants approval for second vaccine
2021-01-13
On 12 January 2021, Swissmedic, the Swiss agency for the authorisation and supervision of pharmaceutical products, approved a second vaccination against the SARS-CoV-2 virus for the Swiss market.
Tags: Coronavirus Switzerland,Covid-19 Switzerland,Editor's Choice,Featured,Health,newsletter